Core Laboratories N.V. (CLB) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	519.2M	526.5M	523.8M	509.8M	489.7M
Cost of Revenue	425.1M	432.2M	435.5M	415.7M	410.8M
Gross Profit	94.1M	94.3M	88.4M	94.0M	78.9M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	45.8M	44.2M	38.6M	38.9M	38.1M
General & Admin Expense	45.8M	44.2M	38.6M	40.3M	38.1M
Selling & Marketing Expense	—	—	—	(1.4M)	—
Other Expenses	234.0K	(429.0K)	(8.8M)	515.0K	(722.0K)
Total Operating Expenses	46.0M	43.8M	29.8M	39.4M	37.4M
Cost and Expenses	471.1M	476.0M	465.3M	455.1M	448.2M
Operating Income (EBIT)	48.0M	50.5M	58.6M	54.6M	41.5M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	11.0M	10.6M	12.4M	13.4M	11.6M
Net Interest Income	(11.0M)	(10.6M)	(12.4M)	(13.4M)	(11.6M)
Other Non-Op Income/Expense	(11.2M)	(4.6M)	(12.4M)	(13.4M)	(11.6M)
Non-Operating Income (excl Interest)	242.0K	(6.0M)	—	—	—
EBT (Pre-Tax Income)	36.8M	45.9M	46.2M	41.2M	30.0M
Income Tax Expense	12.1M	15.5M	14.0M	4.2M	10.3M
Bottom Line
Net Income	24.4M	29.7M	31.4M	36.7M	19.5M
Earnings from Cont. Ops	24.7M	30.4M	32.2M	37.0M	19.7M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	24.4M	29.7M	31.4M	36.7M	19.5M
Per Share
Basic EPS	$0.56	$0.68	$0.67	$0.79	$0.42
Diluted EPS	$0.56	$0.68	$0.66	$0.77	$0.42
Revenue Per Share	$11.08	$11.32	$11.17	$10.92	$10.57
Shares
Basic Shares Outstanding	46.9M	46.5M	46.9M	46.7M	46.3M
Diluted Shares Outstanding	46.9M	46.5M	47.7M	47.5M	46.8M
Profitability Metrics
EBITDA	62.6M	71.1M	73.5M	70.4M	58.7M
D&A	14.9M	14.6M	15.0M	15.8M	17.2M
EBIT	47.8M	56.5M	58.6M	54.6M	41.5M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026